Jiangzhong Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: September 15, 2014
Pages: 50
Price:
US$ 499.00
Jiangzhong Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default), Hard Copy Mail Delivery (+US$ 190.00)
ID: JD403470B7CBEN
Leaflet:

Download PDF Leaflet

Jiangzhong Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Jiangzhong Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Jiangzhong Pharmaceutical Co., Ltd. and its competitors. This provides our Clients with a clear understanding of Jiangzhong Pharmaceutical Co., Ltd. position in the Pharmaceuticals and Biotechnology Industry.

  • The report contains detailed information about Jiangzhong Pharmaceutical Co., Ltd. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Jiangzhong Pharmaceutical Co., Ltd.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Jiangzhong Pharmaceutical Co., Ltd. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Jiangzhong Pharmaceutical Co., Ltd. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Jiangzhong Pharmaceutical Co., Ltd. business.

About Jiangzhong Pharmaceutical Co., Ltd.

Jiangzhong Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical medicines in the People’s Republic of China. The company’s over the counter (OTC) products include Jianwei Xiaoshi tablet that is intended to the symptoms of the loose of appetite, abdominal distention, spontaneous perspiration, hypodynamia and abnormal stool, resulted from impairment of spleen and stomach when children have eaten too much; Compound Sarcandra glabra Buccal tablet, which is intended to pharyngitis caused by external contraction of wind heat, with symptoms of swelling and sore throat, hoarse, and obmutescence; and Scaphium lychnophorum throat-clearing buccal tablets. Its other OTC products include Ganmao Zhike Keli for treating cold and fever, headache, stuffed nose, cough, swelling and sore throat, limb lassitude, and flu; and Zhikang Pian that is active against hemafecia. The company’s chemical products comprise penicillin and cephalosporin products. Its penicillin products consist of penicillin industry salt, penicillin series material medicine, penicillamine, Sulbactam material and penicillin preparation, and cephalosperin preparationi and solid preparation. Its other product lines comprise material medicine, powder ampoule, and solid preparation and compound. In addition, the company engages in the real estate activities. Jiangzhong Pharmaceutical Co., Ltd. is based in Nanchang, the People's Republic of China.


RESEARCH METHODOLOGY

DISCLAIMER

1. JIANGZHONG PHARMACEUTICAL CO., LTD. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. JIANGZHONG PHARMACEUTICAL CO., LTD. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. JIANGZHONG PHARMACEUTICAL CO., LTD. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. JIANGZHONG PHARMACEUTICAL CO., LTD. FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. JIANGZHONG PHARMACEUTICAL CO., LTD. COMPETITORS AND INDUSTRY ANALYSIS

5.1. Jiangzhong Pharmaceutical Co., Ltd. Direct Competitors
5.2. Comparison of Jiangzhong Pharmaceutical Co., Ltd. and Direct Competitors Financial Ratios
5.3. Comparison of Jiangzhong Pharmaceutical Co., Ltd. and Direct Competitors Stock Charts
5.4. Jiangzhong Pharmaceutical Co., Ltd. Industry Analysis
  5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
  5.4.2. Jiangzhong Pharmaceutical Co., Ltd. Industry Position Analysis

6. JIANGZHONG PHARMACEUTICAL CO., LTD. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. JIANGZHONG PHARMACEUTICAL CO., LTD. EXPERTS REVIEW1

7.1. Experts Opinion
7.2. Experts Estimates

8. JIANGZHONG PHARMACEUTICAL CO., LTD. ENHANCED SWOT ANALYSIS2

9. JIANGZHONG PHARMACEUTICAL CO., LTD. PESTEL ANALYSIS2

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. JIANGZHONG PHARMACEUTICAL CO., LTD. PORTER FIVE FORCES ANALYSIS2

11. JIANGZHONG PHARMACEUTICAL CO., LTD. VRIO ANALYSIS2


APPENDIX 1: RATIO DEFINITIONS


LIST OF TABLES

Jiangzhong Pharmaceutical Co., Ltd. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Jiangzhong Pharmaceutical Co., Ltd. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Jiangzhong Pharmaceutical Co., Ltd. Major Shareholders
Jiangzhong Pharmaceutical Co., Ltd. History
Jiangzhong Pharmaceutical Co., Ltd. Products
Revenues by Product
Revenues by Region
Jiangzhong Pharmaceutical Co., Ltd. Offices and Representations
Jiangzhong Pharmaceutical Co., Ltd. SWOT Analysis
Income Statement 2010-2013 Including 4-years Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet 2010-2013 Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow 2010-2013 Including Trends
Cash Flow Latest 4 Quarters Including Trends
Jiangzhong Pharmaceutical Co., Ltd. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Jiangzhong Pharmaceutical Co., Ltd. Capital Market Snapshot
Jiangzhong Pharmaceutical Co., Ltd. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Jiangzhong Pharmaceutical Co., Ltd. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Jiangzhong Pharmaceutical Co., Ltd. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1
Enhanced SWOT Analysis2
Porter Five Forces Analysis2

LIST OF FIGURES

Jiangzhong Pharmaceutical Co., Ltd. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Jiangzhong Pharmaceutical Co., Ltd. 1-year Stock Charts
Jiangzhong Pharmaceutical Co., Ltd. 5-year Stock Charts
Jiangzhong Pharmaceutical Co., Ltd. vs. Main Indexes 1-year Stock Chart
Jiangzhong Pharmaceutical Co., Ltd. vs. Direct Competitors 1-year Stock Charts
Jiangzhong Pharmaceutical Co., Ltd. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for public traded companies.

The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price. Please note that preparation of additional types of analyses requires extra time.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a Project Plan to improve its business performance.


PESTEL Analysis

PESTEL (also termed as STEP, PESTLE, STEEP, STEEPLE, STEEPLED, etc.) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislations will exert influence on the style the business is carried out?

Porter Five Forces Analysis

The extended Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions followed by sixth question added to the original concept:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?
  6. Is there any complementary products, government decisions or public perception that can impact business?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to Imitate?
  • Organized Properly?

Ask Your Question

Jiangzhong Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: